$2.59
-0.04-1.52%
At close: -
$2.59
0.000.00%
After Hours: 4:19 PM EDT
Comments
Loading...
Vistagen Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VTGN | Benzinga
Vistagen Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jun 10
EPS Estimate
$-0.520
Quarterly Revenue Estimate
$179.25K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$698.00K
Analyze the earnings history of Vistagen Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VTGN | VistaGen Therapeutics | -$0.25 | -$0.52 | — | — | $197.30K | $179.25K | — | — | 06/10/2025 | Get Alert |
| VTGN | VistaGen Therapeutics | -$0.22 | -$0.52 | -$0.46 | 11.54% | $411.40K | $179.25K | $234.00K | 30.54% | 02/13/2025 | Get Alert |
| VTGN | VistaGen Therapeutics | -$0.66 | -$0.39 | -$0.42 | -7.69% | $277.70K | $220.00K | $183.00K | -16.82% | 11/07/2024 | Get Alert |
| VTGN | VistaGen Therapeutics | -$0.94 | -$0.40 | -$0.35 | 12.50% | $177.60K | $300.00K | $84.00K | -72.00% | 08/13/2024 | Get Alert |
| VTGN | VistaGen Therapeutics | -$1.61 | -$0.37 | -$0.25 | 32.43% | $175.60K | $410.00K | $197.30K | -51.88% | 06/11/2024 | Get Alert |
| VTGN | VistaGen Therapeutics | -$1.42 | -$0.30 | -$0.22 | 26.67% | $179.60K | $540.00K | $411.40K | -23.81% | 02/13/2024 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.40 | -$0.68 | -$0.66 | 2.94% | -$892.50K | $180.00K | $277.70K | 54.28% | 11/09/2023 | Get Alert |
| VTGN | VistaGen Therapeutics | -$3.00 | — | -$0.94 | — | $310.10K | — | $177.60K | — | 08/10/2023 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.70 | — | -$1.61 | — | $38.90K | — | $175.60K | — | 06/28/2023 | Get Alert |
| VTGN | VistaGen Therapeutics | -$1.50 | -$2.10 | -$1.50 | 28.57% | $357.90K | $150.00K | $179.60K | 19.73% | 02/07/2023 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.10 | -$2.10 | -$2.40 | -14.29% | $358.00K | $310.00K | -$892.50K | -387.90% | 11/10/2022 | Get Alert |
| VTGN | VistaGen Therapeutics | -$1.20 | -$2.10 | -$3.00 | -42.86% | $354.10K | — | $310.10K | — | 08/11/2022 | Get Alert |
| VTGN | VistaGen Therapeutics | -$9.00 | -$1.80 | -$2.70 | -50.00% | $441.90K | $350.00K | $38.90K | -88.89% | 06/23/2022 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.10 | -$2.10 | -$1.50 | 28.57% | $313.60K | $250.00K | $357.90K | 43.16% | 02/10/2022 | Get Alert |
| VTGN | VistaGen Therapeutics | -$1.50 | -$1.80 | -$2.10 | -16.67% | $334.00K | $260.00K | $358.00K | 37.69% | 11/10/2021 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.10 | -$1.50 | -$1.20 | 20.00% | $0.00 | $380.00K | $354.10K | -6.82% | 08/12/2021 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.10 | -$1.50 | -$9.00 | -500.00% | $0.00 | $230.00K | $441.90K | 92.13% | 06/29/2021 | Get Alert |
| VTGN | VistaGen Therapeutics | -$4.50 | -$1.50 | -$2.10 | -40.00% | $0.00 | $210.00K | $313.60K | 49.33% | 02/11/2021 | Get Alert |
| VTGN | VistaGen Therapeutics | -$3.90 | -$0.60 | -$1.50 | -150.00% | $0.00 | $1.67M | $334.00K | -80.00% | 11/12/2020 | Get Alert |
| VTGN | VistaGen Therapeutics | -$4.50 | -$3.60 | -$2.10 | 41.67% | $0.00 | — | $0.00 | — | 08/13/2020 | Get Alert |
| VTGN | VistaGen Therapeutics | -$0.15 | -$2.40 | -$2.10 | 12.50% | $0.00 | — | $0.00 | — | 06/29/2020 | Get Alert |
Vistagen Therapeutics (VTGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-02-13 | $-0.46 | $-0.52 | 11.5 % |
| Q2 | 2024-11-07 | $-0.42 | $-0.39 | -7.69 % |
| Q1 | 2024-08-13 | $-0.35 | $-0.40 | 12.5 % |
| Q4 | 2024-06-11 | $-0.25 | $-0.37 | 32.4 % |
Vistagen Therapeutics (VTGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-02-13 | $234.00K | $179.25K | 30.5 % |
| Q2 | 2024-11-07 | $183.00K | $220.00K | -16.8 % |
| Q1 | 2024-08-13 | $84.00K | $300.00K | -72.0 % |
| Q4 | 2024-06-11 | $197.30K | $410.00K | -51.9 % |
FAQ
When is Vistagen Therapeutics (NASDAQ:VTGN) reporting earnings?
Vistagen Therapeutics (VTGN) is scheduled to report earnings on June 10, 2025. The last reported earnings were for reported on February 13, 2025 for Q3.
What were the latest earnings per share (EPS) for Vistagen Therapeutics (NASDAQ:VTGN)?
The Actual EPS was $-0.46, which beat the estimate of $-0.52.
What were Vistagen Therapeutics’s (NASDAQ:VTGN) revenues?
The Actual Revenue was $234K, which beat the estimate of $179.3K.
Browse earnings estimates, EPS, and revenue on all stocks.